214 related articles for article (PubMed ID: 29288767)
41. Expression of the kcnk3 potassium channel gene lessens the injury from cerebral ischemia, most likely by a general influence on blood pressure.
Muhammad S; Aller MI; Maser-Gluth C; Schwaninger M; Wisden W
Neuroscience; 2010 May; 167(3):758-64. PubMed ID: 20167264
[TBL] [Abstract][Full Text] [Related]
42. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.
Zhang HY; Gao M; Liu QR; Bi GH; Li X; Yang HJ; Gardner EL; Wu J; Xi ZX
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E5007-15. PubMed ID: 25368177
[TBL] [Abstract][Full Text] [Related]
43. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
44. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
Teixeira-Clerc F; Julien B; Grenard P; Tran Van Nhieu J; Deveaux V; Li L; Serriere-Lanneau V; Ledent C; Mallat A; Lotersztajn S
Nat Med; 2006 Jun; 12(6):671-6. PubMed ID: 16715087
[TBL] [Abstract][Full Text] [Related]
45. Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury.
Wang PF; Jiang LS; Bu J; Huang XJ; Song W; Du YP; He B
J Cardiovasc Pharmacol; 2012 Apr; 59(4):301-7. PubMed ID: 22113346
[TBL] [Abstract][Full Text] [Related]
46. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
Wagner JA; Abesser M; Harvey-White J; Ertl G
J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
[TBL] [Abstract][Full Text] [Related]
47. CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory.
Li Y; Kim J
Neural Plast; 2016; 2016():9817089. PubMed ID: 26819779
[TBL] [Abstract][Full Text] [Related]
48. CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury.
Lopez-Rodriguez AB; Mela V; Acaz-Fonseca E; Garcia-Segura LM; Viveros MP
Exp Neurol; 2016 May; 279():274-282. PubMed ID: 27006282
[TBL] [Abstract][Full Text] [Related]
49. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
50. Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain.
La Porta C; Bura SA; Llorente-Onaindia J; Pastor A; Navarrete F; García-Gutiérrez MS; De la Torre R; Manzanares J; Monfort J; Maldonado R
Pain; 2015 Oct; 156(10):2001-2012. PubMed ID: 26067584
[TBL] [Abstract][Full Text] [Related]
51. Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain.
Ashton JC; Rahman RM; Nair SM; Sutherland BA; Glass M; Appleton I
Neurosci Lett; 2007 Jan; 412(2):114-7. PubMed ID: 17123706
[TBL] [Abstract][Full Text] [Related]
52. Functional CB2 type cannabinoid receptors at CNS synapses.
Morgan NH; Stanford IM; Woodhall GL
Neuropharmacology; 2009 Sep; 57(4):356-68. PubMed ID: 19616018
[TBL] [Abstract][Full Text] [Related]
53. Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.
Kim J; Li Y
J Physiol; 2015 Feb; 593(4):871-86. PubMed ID: 25504573
[TBL] [Abstract][Full Text] [Related]
54. Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys.
Bouskila J; Harrar V; Javadi P; Beierschmitt A; Palmour R; Casanova C; Bouchard JF; Ptito M
Neural Plast; 2016; 2016():1253245. PubMed ID: 27069692
[TBL] [Abstract][Full Text] [Related]
55. PGD2 DP1 receptor stimulation following stroke ameliorates cerebral blood flow and outcomes.
Ahmad AS
Neuroscience; 2014 Oct; 279():260-8. PubMed ID: 25218962
[TBL] [Abstract][Full Text] [Related]
56. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Wen J; Ribeiro R; Tanaka M; Zhang Y
Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
[TBL] [Abstract][Full Text] [Related]
57. Neuroserpin, a neuroprotective factor in focal ischemic stroke.
Cinelli P; Madani R; Tsuzuki N; Vallet P; Arras M; Zhao CN; Osterwalder T; Rülicke T; Sonderegger P
Mol Cell Neurosci; 2001 Nov; 18(5):443-57. PubMed ID: 11922137
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
[TBL] [Abstract][Full Text] [Related]
59. CB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: A possible mechanism of improved recovery.
Hong J; Nandiwada V; Jones V; Lu M; Warner DS; Mukhopadhyay S; Sheng H
Neurosci Lett; 2015 Jun; 597():19-24. PubMed ID: 25881484
[TBL] [Abstract][Full Text] [Related]
60. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
